Harrison.ai
About Harrison.ai
Harrison.ai is a global health technology company dedicated to scaling healthcare capacity and improving patient outcomes through advanced AI automation. Their clinician-led and patient-first approach focuses on developing AI-powered medical imaging diagnostic support and workflow solutions for both radiology and pathology. These solutions are designed to act as a ‘co-pilot’ for clinicians, enhancing diagnostic speed and accuracy, and facilitating the early detection of critical conditions such as cancer and other medical illnesses.
The company’s offerings include decision-support tools for chest X-rays and non-contrast head CTs, capable of identifying numerous findings and streamlining workflows. They have also developed Harrison.rad.1, a radiology-specific vision language model trained on millions of real-world clinical images and reports, designed to excel at radiology tasks and prioritize factual correctness and clinical helpfulness. Harrison.ai’s technology is clinically deployed at over 1,000 sites across four continents, supporting more than 3,400 clinicians and impacting over 7 million patient lives to date.
Their mission addresses the global shortage of medical professionals and the increasing demand for diagnostics, aiming to provide equitable access to accurate and timely diagnostics regardless of geographical or economic constraints. The AI solutions integrate seamlessly into existing clinical workflows, helping to reduce radiologist workload, improve diagnostic accuracy (e.g., over 45% increase in diagnostic accuracy for radiologists using their technology), and enable earlier detection of treatable conditions.
Focus Areas
Business Intelligence
| Key Investors | Aware Super, ECP, Horizons Ventures, National Reconstruction Fund Corporation (NRFC), Ord Minnett, Wollemi Capital Group, Blackbird Ventures, Alpha JWC Ventures |
| Partnerships | Sonic Healthcare, Apollo Radiology International, I-MED Radiology, AIRAmed, Koios Medical, Lunit, Nanox AI, AZmed, CoLumbo, Lucida Medical, Nicolab, Radiobotics, Therapixel, Us2.AI |
| Acquisitions | Annalise.ai (merged/unified under Harrison.ai brand) |
| Technology | AI operating system, Open Platform (radically open architecture, zero markup), proprietary large language model (Harrison.rad.1), cloud-native |
| FDA Clearances | 13 radiological findings (across 9 510(k) submissions), 3 FDA Breakthrough Device Designations cleared products (estimated) |
What Physicians Need to Know
Harrison.ai's solutions act as an 'AI co-pilot' or 'second pair of eyes' for physicians, enhancing diagnostic confidence and reducing stress, particularly for junior doctors or during high-volume shifts. The AI prioritizes urgent findings, leading to faster diagnosis and treatment pathways. Its comprehensive detection capabilities help catch subtle and incidental findings that might otherwise be missed, improving overall diagnostic accuracy. The transparent and explainable AI features, such as localization and confidence bars, aid in clinical decision-making. Furthermore, the customizable features allow physicians to tailor the AI's sensitivity and specificity to their specific clinical settings and patient populations. The Harrison.ai Open Platform provides physicians with unprecedented choice and flexibility to access a wide array of best-in-class AI algorithms from multiple vendors through a single, cost-effective integration.
Harrison.ai emphasizes seamless integration into existing clinical workflows, including PACS, RIS, and EMR systems, with a user-friendly, 'no-click' viewer. A key differentiator is the Harrison.ai Open Platform, which offers a 'radically open architecture' and 'zero markup' model. This platform allows healthcare organizations to integrate once and access a diverse catalog of AI applications from Harrison.ai and third-party vendors (e.g., AZmed, Lucida Medical, Nicolab, Radiobotics, CoLumbo, Us2.AI, AIRAmed, Koios Medical, Lunit, Nanox AI), even those that compete directly. This approach aims to eliminate traditional platform fees and vendor lock-in, providing greater choice and transparency in medical imaging AI adoption.
What the Web Says
Harrison.ai is an Australian-based company specializing in AI-powered diagnostic solutions for healthcare, particularly in radiology and medical imaging. The company aims to scale global healthcare capacity by assisting clinicians with earlier and more accurate diagnoses. They have developed AI tools for chest X-rays and non-contrast head CTs, identifying multiple findings rapidly.
Overall: MixedStrengths
- AI solutions help prioritize urgent cases and reduce report turnaround time for critical conditions.
- Products are trained on large datasets with extensive expert annotations, ensuring robust validation.
- Seamless integration with existing PACS/RIS workflows.
- Offers a flexible work environment and employee benefits.
- Nurtures a positive work culture that supports employee growth and encourages innovation.
- Employees are encouraged to volunteer with paid leave for charitable activities.
Limitations
- Some concerns have been raised regarding the ethical collection and use of patient data for training their AI, particularly concerning consent and privacy.
- The company primarily considers candidates with existing expertise in their field, which might be a barrier for some job seekers.
- Limited public reviews available on major platforms like G2, Glassdoor, and Capterra specifically for Harrison.ai's products or as an employer.
- One Reddit discussion from 2023 indicates that AI radiologists are still a long way from replacing human radiologists.
Based on reviews from: Prosple Australia, Elion Health, SourceForge, Hatch, Harrison.ai Official Website, Indeed.com, G2, Reddit
Last updated: 2026-08-04
Videos
News, demos, and interviews about Harrison.ai.
Videos load interactively. If none appear, search YouTube for Harrison.ai →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Harrison.ai.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]